ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
1 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
58
|
7.8K
|
1
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
1 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
58
|
7.8K
|
1
|
|
ASX - By Stock
|
ISD |
Re:
Ann: Isentia H1 FY19 Results and Strategy Presentation
|
|
geffa9
|
62 |
9.2K |
2 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
62
|
9.2K
|
2
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
3 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
58
|
7.8K
|
3
|
|
ASX - By Stock
|
ISD |
Re:
Ann: Isentia H1 FY19 Results and Strategy Presentation
|
|
geffa9
|
62 |
9.2K |
0 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
62
|
9.2K
|
0
|
|
ASX - By Stock
|
ISD |
Re:
Ann: Isentia H1 FY19 Results and Strategy Presentation
|
|
geffa9
|
62 |
9.2K |
3 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
62
|
9.2K
|
3
|
|
ASX - By Stock
|
ISD |
Re:
Ann: Isentia H1 FY19 Results and Strategy Presentation
|
|
geffa9
|
62 |
9.2K |
1 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
62
|
9.2K
|
1
|
|
ASX - By Stock
|
ISD |
Re:
Ann: Isentia H1 FY19 Results and Strategy Presentation
|
|
geffa9
|
62 |
9.2K |
0 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
62
|
9.2K
|
0
|
|
ASX - By Stock
|
ISD |
Re:
Ann: Isentia H1 FY19 Results and Strategy Presentation
|
|
geffa9
|
62 |
9.2K |
3 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
62
|
9.2K
|
3
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
1 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
58
|
7.8K
|
1
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
0 |
21/02/19 |
21/02/19 |
ASX - By Stock
|
200
|
43K
|
0
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
1 |
21/02/19 |
21/02/19 |
ASX - By Stock
|
200
|
43K
|
1
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
1 |
21/02/19 |
21/02/19 |
ASX - By Stock
|
200
|
43K
|
1
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
0 |
21/02/19 |
21/02/19 |
ASX - By Stock
|
58
|
7.8K
|
0
|
|
ASX - By Stock
|
ISD |
Re:
Government contracts
|
|
geffa9
|
22 |
5.6K |
0 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
22
|
5.6K
|
0
|
|
ASX - By Stock
|
ISD |
Re:
Government contracts
|
|
geffa9
|
22 |
5.6K |
2 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
22
|
5.6K
|
2
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
2 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
58
|
7.8K
|
2
|
|
ASX - By Stock
|
ISD |
Re:
Government contracts
|
|
geffa9
|
22 |
5.6K |
2 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
22
|
5.6K
|
2
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
3 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
58
|
7.8K
|
3
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
1 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
58
|
7.8K
|
1
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
0 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
58
|
7.8K
|
0
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
3 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
200
|
43K
|
3
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
0 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
58
|
7.8K
|
0
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Options Prospectus
|
|
geffa9
|
58 |
7.8K |
2 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
58
|
7.8K
|
2
|
|
ASX - By Stock
|
BRK |
Re:
A Private Investor's View - BRK Document
|
|
geffa9
|
27 |
4.1K |
0 |
19/02/19 |
19/02/19 |
ASX - By Stock
|
27
|
4.1K
|
0
|
|
ASX - By Stock
|
BLA |
Re:
Ann: Blue Sky H1 FY19 Results Update
|
|
geffa9
|
51 |
14K |
0 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
51
|
14K
|
0
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
2 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
200
|
43K
|
2
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
0 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
200
|
43K
|
0
|
|
ASX - By Stock
|
BRK |
Re:
A Private Investor's View - BRK Document
|
|
geffa9
|
27 |
4.1K |
4 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
27
|
4.1K
|
4
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
1 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
200
|
43K
|
1
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
4 |
17/02/19 |
17/02/19 |
ASX - By Stock
|
200
|
43K
|
4
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
6 |
17/02/19 |
17/02/19 |
ASX - By Stock
|
200
|
43K
|
6
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
4 |
16/02/19 |
16/02/19 |
ASX - By Stock
|
200
|
43K
|
4
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
0 |
16/02/19 |
16/02/19 |
ASX - By Stock
|
200
|
43K
|
0
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
0 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
0
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
2 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
2
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
0 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
0
|
|
ASX - By Stock
|
DRM |
Re:
Chart
|
|
geffa9
|
29 |
8.0K |
7 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
29
|
8.0K
|
7
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
4 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
4
|
|
ASX - By Stock
|
BRK |
Re:
A Private Investor's View - BRK Document
|
|
geffa9
|
27 |
4.1K |
4 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
27
|
4.1K
|
4
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
7 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
7
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
8 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
8
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
4 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
4
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
1 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
1
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
4 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
4
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
4 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
4
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
0 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
0
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
1 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
1
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
7 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
7
|
|
ASX - By Stock
|
BD1 |
Re:
Ann: Cancer Vaccine Study Results
|
|
geffa9
|
200 |
43K |
2 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
200
|
43K
|
2
|
|